SCHEMBL21596687

SCHEMBL21596687

COc1nc(Cl)c(F)cc1NS(=O)(=O)c1c[nH]c2nc(Cl)ccc12

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 4/20 0.38
PIK3CA P42336 5/20 0.37
PIK3CD O00329 1/20 0.37
PIK3CB P42338 1/20 0.37
PIK3CG P48736 1/20 0.37
SGK1 O00141 4/20 0.36
EIF2AK4 Q9P2K8 2/20 0.36
MAP3K20 Q9NYL2 2/20 0.36
MTOR P42345 1/20 0.35
CYP3A4 P08684 1/20 0.35
EIF2AK3 Q9NZJ5 1/20 0.35
SLC40A1 Q9NP59 1/20 0.35
CCR2 P41597 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29829441 1.00 CCR4 (0.38) CCR4PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL21596708 0.98 CCR4 (0.37) CCR4PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL21596660 0.94 CCR4 (0.39) CCR4PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL29829626 0.94 CCR4 (0.39) CCR4PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL21596665 0.88 CCR4 (0.40) CCR4PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL30991319 0.88 CCR4 (0.40) CCR4PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL29829425 0.88 PIK3CA (0.35) CCR4PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL21596654 0.88 PIK3CA (0.35) CCR4PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL21596670 0.87 PIK3CA (0.38) CCR4PIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL29829629 0.87 PIK3CA (0.38) CCR4PIK3CAPIK3CDPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112469710-B Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2024-05-14 CN claimed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US claimed
EP-3810591-B1 PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2022-08-10 EP claimed
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides UCB PHARMA GMBH (DE) 2021-07-08 US claimed
EP-3810591-A1 PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES UCB Pharma GmbH (DE) 2021-04-28 EP claimed
CN-112469710-A Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2021-03-09 CN claimed
WO-2019243303-A1 PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2019-12-26 WO claimed
CN-112469710-B Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2024-05-14 CN disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 US disclosed
EP-4074703-B1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2023-11-29 EP disclosed
EP-4074703-B1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2023-11-29 EP disclosed
EP-4074703-A1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB Pharma GmbH (DE) 2022-10-19 EP disclosed
EP-4074703-A1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB Pharma GmbH (DE) 2022-10-19 EP disclosed
EP-3810591-B1 PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2022-08-10 EP disclosed
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides UCB PHARMA GMBH (DE) 2021-07-08 US disclosed
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides UCB PHARMA GMBH (DE) 2021-07-08 US disclosed
CN-112469710-A Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2021-03-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides GPR17, GPR18, GPR119 CCR4 3113/4885PIK3CA 2852/4885PIK3CD 2941/4885
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides GPR17, GPR18, GPR119 CCR4 3113/4885PIK3CA 2852/4885PIK3CD 2941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.